Establishment Labs stock, medical devices

Establishment Labs stock falls 3.22 percent after Q2 loss

Published on 09/25/2026 at 11:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Establishment Labs stock posted USD 67.54 million in Q2 revenue, up 31.7 percent year over year. EPS showed a USD 0.39 loss against a USD 0.34 consensus loss.

Establishment Labs stock,  medical devices,  quarterly revenue,  product extensions,  Nasdaq, Illustration mit AI erstellt.
Establishment Labs stock, medical devices, quarterly revenue, product extensions, Nasdaq, Illustration mit AI erstellt.

Establishment Labs stock closed at USD 65.58 on Nasdaq on September 24, 2026, down 3.22 percent from USD 67.76. The move followed a quarter with USD 67.54 million in revenue, while the company continued to report a loss per share.

Revenue reaches USD 67.54 million

For the second quarter ended June 30, 2026, revenue increased 31.7 percent from the same quarter a year earlier, according to Business Wire. Revenue also rose 12.8 percent sequentially from Q1 2026, with United States sales reaching USD 24.7 million.

The earnings profile remained the counterweight to that growth. Establishment Labs posted a loss per share of USD 0.39, missing the USD 0.34 consensus loss by USD 0.05, according to MarketBeat. The figures show a business growing faster than its profitability is improving.

Clinical platform expands

On September 21, 2026, Establishment Labs presented new clinical and scientific data on Breast Tissue Preservation and its Minimally Invasive Platform at the 11th World Symposium on Ergonomic Implants. The company also announced new sizes and supporting tools for Mia and Preserve.

The product update adds an operating dimension to the revenue comparison. The company said its solutions have reached more than 100 countries and that five million Motiva devices have been delivered since 2010, according to Business Wire. That installed product base gives the new extensions a commercial channel beyond a single launch.

Stock remains below yearly high

The September 24 close of USD 65.58 stood below the 52-week high of USD 97.59 and above the 52-week low of USD 37.37. Market capitalization was USD 1.93 billion on the same date.

For investors, the central tension is visible in the numbers: Q2 revenue grew 31.7 percent year over year, while the USD 0.39 per-share loss exceeded the USD 0.34 consensus loss. The September 24 price reaction keeps profitability alongside product adoption as the key measurement.

Establishment Labs market snapshot

  • Company: Establishment Labs Holdings Inc.
  • Ticker: ESTA
  • Trading venue: Nasdaq
  • Closing price (September 24, 2026): USD 65.58
  • Market capitalization: USD 1.93 billion (as of September 24, 2026)
  • 52-week range: USD 37.37-97.59 (as of September 24, 2026)
  • Sector / Industry: Healthcare / Medical Devices

Disclaimer...

en | boerse | 70182672 |